Real-world study tracks COPD patients on new inhaler combo

NCT ID NCT05862545

First seen Mar 23, 2026 · Last updated May 13, 2026 · Updated 8 times

Summary

This study followed 250 adults with COPD in Italy who started a new triple-combination inhaler (budesonide/glycopyrronium/formoterol). Researchers measured how patients felt about their health after 12 weeks and up to a year. The goal was to see how well the treatment works in real-life settings, not just in controlled trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Acquaviva delle Fonti, Italy

  • Research Site

    Alessandria, Italy

  • Research Site

    Ancona, Italy

  • Research Site

    Avellino, Italy

  • Research Site

    Brescia, Italy

  • Research Site

    Brindisi, Italy

  • Research Site

    Busto Arsizio (Varese), Italy

  • Research Site

    Catania, Italy

  • Research Site

    Catanzaro, Italy

  • Research Site

    Cittadella (Padova), Italy

  • Research Site

    Florence, Italy

  • Research Site

    Foggia, Italy

  • Research Site

    Lecce, Italy

  • Research Site

    Naples, Italy

  • Research Site

    Passirana (Milano), Italy

  • Research Site

    Pavia, Italy

  • Research Site

    Roma, Italy

  • Research Site

    Torino, Italy

  • Research Site

    Treviso, Italy

  • Research Site

    Verona, Italy

Conditions

Explore the condition pages connected to this study.